Professor Luigi Martini joins EC as the Editor of the IP Journal
Professor Martini is Chief Scientist for the Royal Pharmaceutical Society (RPS) where he ensures that the RPS stays at the forefront of medicines development and utilization. In this capacity, Professor Martini is often asked to comment in the media and with Government on topical issues such as Brexit, Drug Shortages, Cannabis, Antibiotic Resistance and Drug Discovery to name but a few.
Professor Martini is a registered practising Industrial Pharmacist and a Fellow of the Royal Pharmaceutical Society. Professor Martini also divides his time between the RPS and King’s College London as a Visiting Professor in Pharmaceutical Innovation, after having held the Chair in Pharmaceutical Innovation at King’s for 5 years. Professor Martini is also Visiting Professor at the University of Bradford.
Prior to his tenure in Academia, Professor Martini spent over 17 years working at GlaxoSmithKline Pharmaceuticals, Roche Products Ltd and Shire Pharmaceuticals working in a variety of Technical, Commercial, Innovation based and Medical Affairs roles, directing groups in the US, Europe and Emerging Markets.
Professor Martini has an MBA specialising in SME success and business failure awarded with Distinction from the University of Liverpool.
Professor Martini is past Chair of the Industrial Pharmacists Group of the Royal Pharmaceutical Society and past President of the European Industrial Pharmacists Group.
In 2016, Professor Martini was appointed a Fellow of the European Industrial Pharmacists Group.